Diagnosing Dementing Disease: A Neurologist’s QI Wish List

Imaging can play a valuable role in the early diagnosis of dementing disease. In a special-interest session held on November 26, 2012, at the annual meeting...

Applications of Cumulative Dose Estimates: More Information Needed

As health care organizations in California and across the country work to develop the infrastructure necessary to track patients’ cumulative radiation dose, the question...

Changing the CT Dose Climate: William W. Backus Hospital Case Study

Jenifer Siegelman, MD, a radiologist with Norwich Diagnostic Imaging (NDI), had noticed something disturbing about the CT images coming out of the hospital her...

NLST Proves Lives Can Be Saved: Now Comes the Difficult Step of Implementation

One of the most extensive and ambitious medical-screening trials in US has been stopped. It’s because of good news: Low-dose helical CT (LDCT)...

Imaging in Clinical Trials: Endpoints, Biomarkers, and Methods

This article is the second in a series of three providing a background and primer to radiologists and imaging professionals interested in clinical trials....

Novel Biomarker Rivals SAP in Amyloid Imaging Using SPECT/CT

The winning entry, left, in a recent vendor-sponsored preclinical- imaging competition presented at the World Molecular Imaging Conference in Kyoto, Japan, compared the amyloid-binding efficacy...

Keeping Radiology on the Cutting Edge

Over the past two decades, imaging has undergone revolutionary and evolutionary changes in both the clinical and nonclinical spheres. Part of this evolution has...

Contract Research Organizations: Radiology’s Newest Revenue Stream

In the not-too-distant past, the use of imaging as an endpoint in clinical trials was at best considered a novel approach by pharmaceutical and...


The Jig Is Up

For many years, hospitals and physician practices have engaged with payors in a little game we play in a free market society called “negotiation.” This game enables the players to use whatever tools and stratagems they possess to leverage as good a price possible for their services/business in an increasingly price-conscious marketplace. On the provider side, good means high, and on the payor side, good means low. Providers might negotiate from a position



Resources
Share Use